The potential risk of AVM rupture was evaluated in the A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) demo. This research uncovered a reduced hazard of stroke and mortality in sufferers managed conservatively as opposed to patients who underwent interventional therapy.[13]  The ARUBA trial as opposed healthcare management by https://www.sgvascularctr.com/service/vascular-malformations/